Ifeoma Chukwuma

Dr. Ifeoma Chukwuma

Department of Biochemistry, University of Nigeria, Nsukka, Nigeria.

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2024 in Journal of Global Health Economics and Policy
Verified
Journal Article
Open access
PDF file
OEOkechukwu Ignatius Eze
Okechukwu Ignatius Eze
ICIfeoma Chukwuma
Ifeoma Chukwuma
The recent surge in enrolment in Nigeria’s National Health Insurance Scheme (NHIS) of 11% in Q4 of 2023 presents a critical opportunity to assess its potential for improving healthcare outcomes and reducing poverty, particularly in rural areas. Given the significant healthcare infrastructure and personnel disparities across Nigeria’s rural regions, this paper investigates whether health insurance can effectively achieve these goals. We stress the importance of workforce development in this context. Despite the theoretical advantages of health insurance in enhancing access to care and alleviating financial burdens, its impact in rural areas is severely constrained by a lack of healthcare professionals and facilities. These systemic deficits limit access to quality care, undermining the potential benefits of expanded insurance coverage. We argue that while expanding health insurance is essential, it is insufficient to generate substantial improvements in health outcomes or meaningful poverty reduction without concurrent investments in healthcare infrastructure and workforce development. Furthermore, we propose a phased strategy that prioritizes strengthening healthcare facilities and increasing the availability of healthcare professionals in rural areas, followed by broader insurance coverage expansion. This approach ensures that the gains from health insurance translate into real improvements in healthcare access, outcomes, and long-term poverty reduction, thereby enhancing services for underserved populations.

23 November 2022 in Scientific African
Verified
Journal Article
Open access
COChioma Obiageli Onyesife
Chioma Obiageli Onyesife
ICIfeoma Chukwuma
Ifeoma Chukwuma
IOInnocent Okagu
Innocent Okagu
JNJoseph Chinedum Ndefo
Joseph Chinedum Ndefo
NANkechi Angela Amujiri
Nkechi Angela Amujiri
VOVictor Nwadiogo Ogugua
Victor Nwadiogo Ogugua

23 November 2021 in Arabian Journal of Chemistry
Verified
Journal Article
Open access
VAVictor Onukwube Apeh
Victor Onukwube Apeh
ONObioma Uzoma Njoku
Obioma Uzoma Njoku
FNFred Okwesili C. Nwodo
Fred Okwesili C. Nwodo
ICIfeoma Chukwuma
Ifeoma Chukwuma
AAAbayomi Emmanuel Adegboyega
Abayomi Emmanuel Adegboyega
Citrullus lanatus seed is an important but neglected seed rich in essential fatty acids. The study sought to investigate in silico and in vivo antifungal activity of some bioactive compounds of Citrullus lanatus (watermelon) seed oil (CLSO) on oral candidiasis induced by Candida albicans in immunosuppressed female albino rats and to predict the Absorption, Distribution, Metabolism and Excretion (ADME) properties of isolated natural compound. Docking studies was performed using standard procedure, standard microbiological and histopathological techniques was employed for study of in vivo antifungal activity of the oil; as well as renal function tests at days 7 and 14 post-infection treatments. Treated groups were compared with that of the control groups. In vitro studies showed varied zone of inhibitions at different concentrations. Ligand-protein interaction showed better binding activity between Palmitic acid and SAP-5 as well as CYP51 when compared with fluconazole (reference drug). Treatment with CLSO showed that there was a significant reduction in the kidney fungal burden (cfu/ml/g) of rats treated with CLSO after 14 days post-infection treatment, compared to group 2 (untreated control) rats. Histomorphology of group 2 showed multifocal aggregation and widespread distribution of fungal blastospores when compared with CLSO-treated groups, which had minimal fungal blastospores in the renal tissues. Thus, in silico and histological data agreed with the findings in microbiology. Furthermore, within the CLSO treated group, a significant increase in the serum concentrations of creatinine was observed, while no significant difference in blood urea values was recorded after day 14 post-infection study. Linoleic and palmitic acid could be considered as a potential antifungal drug candidate with palmitic acid playing a significant role.

2 January 2024 in BMC Complementary Medicine and Therapies
Verified
Journal Article
Open access
PDF file
NINgozi Dorathy Idoko
Ngozi Dorathy Idoko
ICIfeoma Chukwuma
Ifeoma Chukwuma
FNFlorence Nkechi Nworah
Florence Nkechi Nworah
SMSopuruchukwu Elizabeth Mba
Sopuruchukwu Elizabeth Mba
PJParker Elijah Joshua
Parker Elijah Joshua
MWMichel de Waard
Michel de Waard
Background: Immunological abnormalities are implicated in the pathogenesis of many chronic diseases. Due to the drug-related adverse effects of currently available orthodox immunomodulators, natural immunomodulators are being looked upon as potential agents to replace them in therapeutic regimens. This research aimed to investigate the immunomodulatory potential ofL. micranthusextracts epiphytic onPsidium guajava(LMPGE) andParkia biglobosa(LMPBE).Methods: Phytochemical screening and acute toxicity testing were carried out to identify the phytoconstituents and safety profiles of the extracts. The extracts’ innate and adaptive immunomodulatory potentials were determined in experimental animals using in vivo leucocyte mobilization, delayed-type hypersensitivity (DTH) response, hemagglutination antibody titre, and cyclophosphamide-induced myelosuppression models. Levamisole was used as the standard drug throughout the study.Results: Compared to LMPBE, LMPGE contained significantly (p < 0.05) more tannins, cyanogenic glycosides, saponins, reducing sugars, glycosides, flavonoids, and alkaloids. Furthermore, the groups treated with the extracts had a significant (p < 0.05) increase in the total number of leucocytes, neutrophils, basophils, and antibody titers relative to the untreated control. In the same way, the treatment raised TLC in cyclophosphamide-intoxicated rats, with 250 mg/kg b. w. of LMPGE and LMPBE recording 9712.50 ± 178.00 and 8000.00 ± 105.00 × 109 /L, respectively, compared to 3425.00 ± 2 5.00 × 109 /L in the untreated group. Overall, LMPGE was more effective.Conclusions: The findings from this study suggest thatL. micranthusepiphytic inPsidium guajavaandParkia biglobosahas possible immune stimulating potential.

2 January 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ICIfeoma Chukwuma
Ifeoma Chukwuma
EOEmmanuel Chekwube Ossai
Emmanuel Chekwube Ossai
FNFlorence Nkechi Nworah
Florence Nkechi Nworah
VAVictor Onukwube Apeh
Victor Onukwube Apeh
EAEmmanuel Osinachi Abiaziem
Emmanuel Osinachi Abiaziem
MKMałgorzata Korzeniowska
Małgorzata Korzeniowska
Tropical almond (Terminalia catappa Linn.) is highly distributed within the tropics, but appears rather underutilized in developing countries like Nigeria. Specifically, relevant information regards the nutritional, health benefits, and pharmaceutical potential of roasted T. catappa nuts remains scanty. Comparing both raw and roasted T. catappa nuts should provide additional information especially from product development and potential commercial prospect standpoints. The changes in nutritional, health benefits, and pharmaceutical potentials of raw and roasted T. catappa nuts were, therefore, investigated. Whereas the raw T. catappa nuts obtained significantly (p < 0.05) higher protein, ash, moisture, crude fiber, as well as vitamins C, and B1-3 compared to the roasted ones, some contents like carbohydrates, energy, vitamin A, calcium, manganese, zinc, hydrogen cyanide, as well as oxalate would noticeably change (p < 0.05) after the roasting process. Twenty phytochemicals were identified in both raw and roasted samples with the concentrations of quinine, ribalinidine, sapogenin, flavan-3-ol and tannin significantly reduced, while catechin seemed enhanced upon roasting. Promising drug-likeness, pharmacokinetic properties, and safety profiles could be predicted among the phytochemicals. Overall, roasting T. catappa nuts should enhance the nutritional contents, which could aid both absorption and palatability.

23 August 2024 in Heliyon
Verified
Journal Article
Open access
ICIfeoma Chukwuma
Ifeoma Chukwuma
Kennedy Chinedu OkaforKennedy Chinedu Okafor
Kennedy Chinedu Okafor
VAVictor Onukwube Apeh
Victor Onukwube Apeh
FNFlorence Nkechi Nworah
Florence Nkechi Nworah
COChigozie Paul Odo
Chigozie Paul Odo
OAOkoronkwo Chukwunenye Anthony
Okoronkwo Chukwunenye Anthony
The quest for novel antioxidant and anti-inflammatory medications from medicinal plants is crucial since the plants contain bioactive compounds with a better efficacy and safety profile than orthodox therapy. This study harnesses the capabilities of mechatronics-driven Agilent Gas Chromatography, deploying in vitro, in vivo, and in silico models to unravel the antioxidant and anti-inflammatory attributes within Combretum paniculatum ethanol extract (CPEE). Employing gas chromatography-mass spectroscopy (GC-MS), our analysis efficiently segregates and evaluates volatile compound mixtures, a technique renowned for identifying organic compounds, as exemplified by its success in detecting fatty acids in food and resin acids in water. Using gas chromatography-mass spectrometry (GC-MS) and GC-FID analyses, this paper ascertains the comprehensive phytochemical composition of CPEE. Also, Molecular interactions of identified compounds with cyclooxygenase (COX-2) implicated in inflammatory urpsurge is verified. GC-MS and GC-FID analyses unveil 41 phytoconstituents within CPEE. Based on the in vitro research, CPEE demonstrated potential in inhibiting thiobarbituric acid-reactive substances, nitric oxide, and phospholipase lipase A2 with inhibition rates of 2.284, 6.547, and 66.8 μg/mL respectively. In vivo experiments confirm CPEE's efficacy in inhibiting granuloma tissue formation, lipid peroxidation, and neutrophil counts compared to untreated rats. Moreover, CPEE elicited a significant (P < 0.05) increase in the activities of SOD, CAT, and GSH concentrations while decreasing C-reactive protein, signifying promising therapeutic potential. Highlighting interactions between top-scoring phytoligands (epicatechin, catechin, and kaempferol) and COX-2, the findings underscore their drug-like characteristics, favorable pharmacokinetics, and enhanced safety toxicity profiles. Results from in vitro, in vivo, and in silico studies, highlights CPEE remarkable antioxidant and anti-inflammatory potentials.